본문 바로가기
KERD
논문KCI 등재

The Relationship between Uterine Myoma Growth and the Endocrine Disruptor in Postmenopausal Women

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

초록

Objectives: To investigate the number of leiomyoma patients-exposed to bisphenol A (BPA) and to observe whether the serum concentration of BPA is related to leiomyoma growth. Methods: A total of 158 patients were recruited for this study. Leiomyoma patients were divided into three groups, mild (n = 48), moderate (n = 32) and severe (n = 28), according to the size of leiomyomas. The control (n = 30) group was defined as having no leiomyomas. Transvaginal ultrasonography was used to identify and measure the leiomyomas. Serum BPA concentrations were measured by enzyme-linked immunosorbent assay. Results: BPA was detected in 87.0% out of a total of 158 samples, and in 86.0% out of 108 leiomyoma patients. In detail, the detection rates of serum BPA were 88.0% in the control group, 77.2% in the mild group, 90.0% in the moderate group and 96.0% in the severe group. The mean BPA concentration in the control group was 0.558 ± 0.097 ng/mL, the leiomyoma groups, the mean BPA concentrations were 0.274 ± 0.063 ng/mL (mild), 0.346 ± 0.064 ng/mL (moderate) and 0.647 ± 0.039 ng/mL (severe) (P = 0.0003). Values repres ent the mean ± standard error. Conclusion: The detection rates of serum BPA in the control and leiomyoma groups were 88.0% and 86.0%, respectively. However, there was no significant difference in the serum BPA concentrations between the control and leiomyoma groups. To verify the effect of BPA on leiomyoma growth, a close and sequential monitoring is recommended for people who are at risk for uterine leiomyoma. (J Menopausal Med 2013;19:130-134)

Abstract

Objectives: To investigate the number of leiomyoma patients-exposed to bisphenol A (BPA) and to observe whether the serum concentration of BPA is related to leiomyoma growth. Methods: A total of 158 patients were recruited for this study. Leiomyoma patients were divided into three groups, mild (n = 48), moderate (n = 32) and severe (n = 28), according to the size of leiomyomas. The control (n = 30) group was defined as having no leiomyomas. Transvaginal ultrasonography was used to identify and measure the leiomyomas. Serum BPA concentrations were measured by enzyme-linked immunosorbent assay. Results: BPA was detected in 87.0% out of a total of 158 samples, and in 86.0% out of 108 leiomyoma patients. In detail, the detection rates of serum BPA were 88.0% in the control group, 77.2% in the mild group, 90.0% in the moderate group and 96.0% in the severe group. The mean BPA concentration in the control group was 0.558 ± 0.097 ng/mL, the leiomyoma groups, the mean BPA concentrations were 0.274 ± 0.063 ng/mL (mild), 0.346 ± 0.064 ng/mL (moderate) and 0.647 ± 0.039 ng/mL (severe) (P = 0.0003). Values repres ent the mean ± standard error. Conclusion: The detection rates of serum BPA in the control and leiomyoma groups were 88.0% and 86.0%, respectively. However, there was no significant difference in the serum BPA concentrations between the control and leiomyoma groups. To verify the effect of BPA on leiomyoma growth, a close and sequential monitoring is recommended for people who are at risk for uterine leiomyoma. (J Menopausal Med 2013;19:130-134)

참고문헌 (18)

  1. Wallach EE, "Uterine myomas: an overview of development, clinical features, and management", Obstet Gynecol, 104, pp.393~406 (2004)
  2. Hunter DS, "Influence of exogenous estrogen receptor ligands on uterine leiomyoma: evidence from an in vitro", in vivo animal model for uterine fibroids, 2000, pp.108(Suppl 5), 829~834
  3. Cao XL, "Levels of bisphenol A in canned liquid infant formula products in Canada and dietary intake estimates", J Agric Food Chem, 56, pp.7919~7924 (2008)
  4. Hiroi H, "Differences in serum bisphenol a concentrations in premenopausal normal women and women with endometrial hyperplasia", Endocr J, 51, pp.595~600 (2004)
  5. Newbold RR, "Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract", Reprod Toxicol, 24, pp.253~258 (2007)
  6. Rosselli M, "Cellular and biochemical mechanisms by which environmental oestrogens influence reproductive function", Hum Reprod Update, 6, pp.332~350 (2000)
  7. Hiroi H, "Differential interactions of bisphenol A and 17beta-estradiol with estrogen receptor alpha (ERalpha) and ERbeta", Endocr J, 46, pp.773~778 (1999)
  8. Stratakis CA, "The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription", J Clin Endocrinol Metab, 83, pp.1348~1357 (1998)
  9. Hess-Wilson JK, "Xenoestrogen action in breast cancer: impact on ERdependent transcription and mitogenesis", Breast Cancer Res Treat, 96, pp.279~292 (2006)
  10. Baird DD, "Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development", Reprod Toxicol, 20, pp.81~84 (2005)
  11. Haishima Y, "Elution of bisphenol-A from hemodialyzers consisting of polycarbonate and polysulfone resins", J Biomed Mater Res, 58, pp.209~215 (2001)
  12. Ikezuki Y, "Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure", Hum Reprod, 17, pp.2839~2841 (2002)
  13. Kuruto-Niwa R, "Measurement of bisphenol A concentrations in human colostrum", Chemosphere, 66, pp.1160~1164 (2007)
  14. Schonfelder G, "In utero exposure to low doses of bisphenol A lead to long-term deleterious effects in the vagina", Neoplasia, 4, pp.98~102 (2002)
  15. Le HH, "Bisphenol A is released from polycarbonate drinking bottles and mimics the neurotoxic actions of estrogen in developing cerebellar neurons", Toxicol Lett, 176, pp.149~156 (2008)
  16. Markey CM, "Long-term effects of fetal exposure to low doses of the xenoestrogen bisphenol-A in the female mouse genital tract", Biol Reprod, 72, pp.1344~1351 (2005)
  17. Takeuchi T, "Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels", Biochem Biophys Res Commun, 291, pp.76~78 (2002)
  18. Hodges LC, "An in vivo", in vitro model to assess endocrine disrupting activity of xenoestrogens in uterine leiomyoma, 2001, pp.948, 100~111

이 간행물의 다른 논문 (7건)